Selpercatinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway.
Li S, Liu Z, Jiao X, Gu J, Liu Z, Meng L, Li W, Zhang T, Liu J, Chai D, Liu J, Yang Z, Liu Y, Jiao R, Li X, Zhou H, Zhang Y.
Li S, et al.
Biochem Pharmacol. 2024 May 16:116282. doi: 10.1016/j.bcp.2024.116282. Online ahead of print.
Biochem Pharmacol. 2024.
PMID: 38762147